Gov. Gretchen Whitmer’s COVID-19 recovery plan requires the state must reach 70% of Michiganders ages 16 and older with a first vaccine injection before dropping all COVID-19 restrictions.
But the state doesn’t know how many residents have already been vaccinated in other states unless residents give that information to the state health department.
Read More
Workers at a Baltimore plant responsible for producing two separate coronavirus vaccines mistakenly mixed up their respective ingredients, ruining approximately 15 million doses of Johnson & Johnson’s vaccine and pausing all production at the plant, the company confirmed Wednesday.
The facility, run by Emergent BioSolutions, had partnered with both Johnson & Johnson and AstraZeneca to produce vaccines. Federal officials said that the mistake was a result of human error, according to The New York Times, which first reported the mix up that reportedly occurred several weeks ago.
A quality control review “identified one batch of drug substance that did not meet quality standards at Emergent BioSolutions, a site not yet authorized to manufacture drug substance for our COVID-19 vaccine,” Johnson & Johnson said in a statement. “This batch was never advanced to the filling and finishing stages of our manufacturing process.”
Read More
Maryland’s vile handling of the COVID-19 vaccine affords searing lessons in the failure of bureaucratic government or the administrative state. More specifically Montgomery County (MoCo), Maryland’s bedroom community for the federal bureaucracy, exemplifies how America will suffer under one-party Democratic rule.
Read More
In a 67-0 vote Monday, the Minnesota Senate passed legislation that will allow dentists to administer the COVID-19 vaccine.
SF 475 is a bill “amending Minnesota Statutes 2020, section 150A.055,” which gives dentists the ability to distribute influenza vaccines. The amendment broadens the original bill, extending to cover COVID-19 vaccinations, too.
Read More
Biotech company Moderna announced Monday that its new COVID-19 vaccine has proven to be 94.5 % effective.
The company said it intends to submit for an Emergency Use Authorization (EUA) with the U.S. Food and Drug Administration in the coming weeks and expects the EUA to be based on the final analysis of 151 cases and a median follow-up of more than two months.
Read More
The Trump administration is expected to announce that the eventual coronavirus vaccine will be covered by Medicare and Medicaid, Politico reported late Monday.
The administration is expected to change a rule that previously prevented Medicare and Medicaid from covering vaccines that received emergency use authorization from the FDA. The official announcement is expected from the Center for Medicare and Medicaid Services (CMS) Tuesday or Wednesday, according to Politico.
Read More
Two drugmakers announced Friday the resumption of U.S. testing of their COVID-19 vaccine candidates.
Testing of AstraZeneca’s vaccine candidate had been halted since early September, while Johnson & Johnson’s vaccine study was paused at the beginning of last week. Each company had a study volunteer develop a serious health issue, requiring a review of safety data.
Read More
CVS Health announced that it would bring on approximately 15,000 additional workers in preparation for the upcoming flu season and an expected rise in coronavirus cases before the distribution of an eventual vaccine.
The hirings will take place before the year’s end, the company said Monday in a statement. Though most of the positions are temporary, many could transition into full-time positions, CVS said.
Read More
The suspension of a huge COVID-19 vaccine study over an illness in a single participant shows there will be “no compromises” on safety in the race to develop the shot, the chief of the National Institutes of Health told Congress on Wednesday.
AstraZeneca has put on hold studies of its vaccine candidate in the U.S. and other countries while it investigates whether a British volunteer’s illness is a side effect or a coincidence.